47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
73.11.Z - Advertising agency activities
73.12.A - Advertising through mass media
73.12.B - Advertising through mass media
73.12.C - Advertising through mass media
73.12.D - Advertising through mass media
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 1,2 | 1,3 | 1,2 | -5,3 |
Gross profit (loss) | 1,3 | 1,3 | 1,2 | -5,9 |
EBITDA | 1,3 | 1,3 | 1,2 | -5,8 |
Short time liabilities | 0,2 | 0,4 | 0,4 | 16,6 |
Other operating costs | 0 | 0 | 0,1 | 20,3 |
Equity capital | 0,9 | 0,9 | 0,8 | -4,3 |
Operating profit (EBIT) | 1,3 | 1,3 | 1,2 | -5,9 |
Assets | 1,2 | 1,3 | 1,3 | -1,7 |
Net profit (loss) | 1,3 | 1,3 | 1,2 | -5,9 |
Cash | 0,1 | 0,1 | 0,1 | 1,9 |
Net income from sale | 9,8 | 10,4 | 10,9 | 4,6 |
Liabilities and provisions for liabilities | 0,4 | 0,4 | 0,4 | 3,7 |
Working assets | 1,1 | 1,2 | 1,2 | -0,2 |
Other income costs | 0,1 | 0 | 0 | 198,7 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 146,4 | 144,1 | 141,7 | -2,4 |
Equity capital to total assets | 71,1 | 67,5 | 65,8 | -1,7 |
Gross profit margin | 13,1 | 12,3 | 11,1 | -1,2 |
EBITDA Margin | 13,2 | 12,5 | 11,2 | -1,3 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 9 | 13 | 15 | 2 |
Current financial liquidity indicator | 4.998692035675049 | 3.2692182064056396 | 2.7973062992095947 | -0,5 |
Net dept to EBITDA | 0.01004581805318594 | -0.07251346856355667 | -0.11781943589448929 | 0 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane